154972-37-9

Basic information

• Product Name: Tetrahydro-pyridazine-1-carboxylic acid tert-butyl ester
• Synonyms: Tetrahydro-pyridazine-1-carboxylic acid tert-butyl ester;Tert-Butyl Tetrahydro-1(2H)-Pyridazinecarboxylate(WX604650)
• CAS NO: 154972-37-9
• Molecular Formula: C₉H₁₈N₂O₂
• Molecular Weight: 186
• Mol File: 154972-37-9.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Tetrahydro-pyridazine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Tetrahydro-pyridazine-1-carboxylic acid tert-butyl ester(154972-37-9)
• EPA Substance Registry System: Tetrahydro-pyridazine-1-carboxylic acid tert-butyl ester(154972-37-9)

Safety Data

• Hazardous Substances Data: 154972-37-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Tetrahydro-pyridazine-1-carboxylic acid tert-butyl ester is used as a key intermediate in the synthesis of various pharmaceutical compounds for its ability to contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, Tetrahydro-pyridazine-1-carboxylic acid tert-butyl ester is utilized as an intermediate in the production of agrochemicals, contributing to the development of effective pesticides and other agricultural chemicals to protect crops and enhance yield.
Used in Organic Synthesis:
Tetrahydro-pyridazine-1-carboxylic acid tert-butyl ester is used as a building block in organic synthesis for its ability to form diverse heterocyclic compounds, which are important in various chemical and pharmaceutical applications due to their unique properties and reactivity.
Used in Research and Development:
Tetrahydro-pyridazine-1-carboxylic acid tert-butyl ester is also used in research and development settings as a versatile chemical entity for exploring new reaction pathways, understanding structure-activity relationships, and discovering novel applications in various fields, including materials science and medicinal chemistry.

Upstream product

• 505-19-1 piperidazine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 57699-88-4 1-tert-butoxycarbonyl-2-carbobenzyloxyhydrazine 
• 154972-38-0 benzyl 2-(tert-butoxycarbonyl)hexahydropyridazine-1-carboxylate 

Downstream Products

• 443295-21-4 tert-butyl 2-(4-nitrobenzoyl)hexahydropyridazine-1-carboxylate 
• 1316663-23-6 C₂₆H₃₉N₃O₅ 
• 89990-53-4 1,2,3,4,5,6-hexahydropyridazine hydrochloride 
• 443295-22-5 tert-butyl 2-(4-methoxybenzoyl)hexahydropyridazine-1-carboxylate 
• 443295-20-3 tert-butyl 2-(4-chlorobenzoyl)hexahydropyridazine-1-carboxylate 

Relevant articles and documents

Peptidomimetic inhibitors of bacterial peptide deformylase

A series of N-formyl hydroxylamine peptide deformylase inhibitors containing a cyclic azaamino acid moiety between the P1′ and P3′ substituents are presented. Selected compounds display antibacterial activity against pathogens associated with respiratory

PYRAZOLE DERIVATIVES

A compound represented by formula (I): (wherein Ar1 represents a phenyl group which may have 1 to 3 substituents, or a non-substituted 5- or 6-membered aromatic heterocyclic group; Ar2 represents (i) a non-substituted phenyl group, (ii) a phenyl group which has been substituted by a lower alkyl group having 1 to 3 groups or atoms selected from among a carbamoyl group, an amino group, a hydroxyl group, a lower alkoxy group, and a halogen atom, or (iii) a 5- or 6-membered nitrogen-containing aromatic heterocyclic group which has been substituted by 1 to 3 groups or atoms selected from among a lower alkyl group, a lower alkynyl group, a lower alkanoyl group, a carbamoyl group, a cyano group, an amino group, a hydroxyl group, a lower alkoxy group, and a halogen atom; and X represents a group represented by formula (II): (wherein the ring structure represents a 4- to 7-membered heterocyclic group which may have, in addition to the nitrogen atom shown in formula (II), one heteroatom selected from among nitrogen, oxygen, and sulfur, and which may be substituted by 1 to 4 groups or atoms selected from among a lower alkyl group, a carbamoyl group, an amino group, a hydroxyl group, a lower alkoxy group, an oxo group, a lower alkanoyl group, a lower alkylsulfonyl group, and a halogen atom)), a salt thereof, a solvate of the compound or the salt, and a drug.

PYRAZOLE DERIVATIVE

A compound represented by Formula (I): wherein Ar1 represents Formula (II): Ar2 represents a 5- or 6-membered aromatic heterocyclic group which may be substituted; and X represents Formula (III): a salt thereof, or a solvate of the compound or the salt. A potent platelet aggregation suppressant which does not inhibit COX-1 and COX-2 is provided.

Novel compounds and therapeutic uses thereof

The invention discloses a novel series of compound represented by general formula (I), its derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, pharmaceutically acceptable salts, solvates wherein X, n, k, z, R1, R2, R3, R4, R5 and R6 are as defined in the specification that are useful in (i) normalizing elevated blood glucose levels in diabetes, (ii) treating disorders related to glucose intolerance and (iii) for scavenging free radicals of mammals. The invention also discloses pharmaceutically acceptable composition comprising these compounds, method for preparation of the compounds as defined above and method of treating mammals including human beings by administering an effective amount of said compounds to a subject in need thereof. The invention further discloses use of these compounds in the manufacture of a medicament useful for treatment of different disease conditions as stated above.

Cyclic dibenzoylhydrazines reproducing the conformation of ecdysone agonists, RH-5849

We have investigated the biologically active conformation of the non-steroidal ecdysone agonist, 1-tert-butyl-1,2-dibenzoylhydrazine (RH-5849) by means of design, synthesis and conformational analysis of cyclic derivatives of RH-5849. Among the synthesize

Azapeptide acids as cell adhesion inhibitors

Azapeptide acids of Formula I are antagonists of VLA-4 and/or alpha 4 beta 7, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds may be formulated into pharmaceutical composition

Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons

The present invention discloses the compounds of general formula (1) STR1 wherein R1, R2, R3 are optionally substituted carbonyl and amide derivatives which are useful as inhibitors of retroviral proteases, and are effecti